Table 4.

Multivariate analysis of predictors of thromboembolism in patients with PNH

VariableORLow 95% CIHigh 95% CIP value
AST >40 U/L 0.73 0.25 2.02 .5434 
ALT >40 U/L 1.79 0.66 4.81 .2472 
Albumin <4.2 g/dL 0.49 0.21 1.11 .0911 
D-dimers >1000 mg/L 1.96 0.54 7.19 .3026 
Reticulocytes >80 × 103/μL 1.05 0.39 2.76 .9271 
ANC <1.5 × 109/L 0.82 0.32 2.13 .6881 
Platelets <100 × 109/L 0.69 0.25 1.93 .4859 
LDH >400 U/L 2.84 1.01 8.30 .0514 
Type II–dominant RBC PNH 4.09 1.32 13.19 .0160 
RBC clonal size >20% 0.70 0.22 2.16 .5438 
Granulocyte clonal size >70% 2.05 0.77 5.56 .1536 
PIGA VAF >15% 2.59 0.72 10.44 .1600 
VariableORLow 95% CIHigh 95% CIP value
AST >40 U/L 0.73 0.25 2.02 .5434 
ALT >40 U/L 1.79 0.66 4.81 .2472 
Albumin <4.2 g/dL 0.49 0.21 1.11 .0911 
D-dimers >1000 mg/L 1.96 0.54 7.19 .3026 
Reticulocytes >80 × 103/μL 1.05 0.39 2.76 .9271 
ANC <1.5 × 109/L 0.82 0.32 2.13 .6881 
Platelets <100 × 109/L 0.69 0.25 1.93 .4859 
LDH >400 U/L 2.84 1.01 8.30 .0514 
Type II–dominant RBC PNH 4.09 1.32 13.19 .0160 
RBC clonal size >20% 0.70 0.22 2.16 .5438 
Granulocyte clonal size >70% 2.05 0.77 5.56 .1536 
PIGA VAF >15% 2.59 0.72 10.44 .1600 

ALT, alanine aminotransferase.

Bold indicates statistical significance.

or Create an Account

Close Modal
Close Modal